PharmIA’s solution comes to UHCs so that AI can solve today’s clinical pharmacy challenges

PharmIA’s solution comes to UHCs so that AI can solve today’s clinical pharmacy challenges

As part of a close collaboration between the Valenciennes Hospital (CHV), the University Hospital (CHUM) and the University of Montpellier and the SATT AXLR, PharmIA is an innovative medical device dedicated to hospital pharmacy. The first deployment of this platform for the analysis of hospital prescriptions was carried out within the CHU of Montpellier. Artificial intelligence is at the heart of the pharmaceutical tool.

A new medical device designed using analytical engines

PharmIA is an innovative medical device, dedicated to hospital pharmacy, which is very much in line with the current challenges of clinical pharmacy: safety, effectiveness and organizational efficiency. Designed with the help of latest generation analytical engines, the tool aims to reduce the iatrogenic risk (a pathological event due to a drug or treatment) and make hospital pharmacy more efficient while deploying telepharmacy strategies.

In terms of operation, the solution detects the most critical cases of iatrogenic effects while facilitating their investigation in real time, always with the objective of achieving enhanced safety and better patient care. In 2021, the platform was CE marked and is already operational at the Valenciennes Hospital while being distributed by major hospital information systems (HIS) publishers.

A solution that came into being thanks to the mobilization of several players and several actions

PharmIA is an innovation rooted in the reality of hospital care, which was made possible by :

  • The essential contribution of Valenciennes Hospital and Montpellier University Hospital in all phases of product development: from the research and design phases to the integration of the HIS, including legal and medical expertise.
  • The ability of SATT AxLR (Société d’Accélération et de Transfert Technologique) to support the project and to set up an initial financing tool based on a public/private partnership, combining the contributions of the 4 initial partners CHV, SATT, QUINTEN and CHU Montpellier.
  • The mobilization of Quinten’s consolidated expertise in the health sector for more than twelve years to develop an intelligent technological platform combining the latest generation of analytical engines with a natural fit with the practices of hospital pharmacists and easy integration into the hospital’s information system.
  • The development of partnerships with Electronic Patient Record (EPR) editors in order to ensure a rapid and massive European deployment in a regulated market. The DEDALUS group is facilitating the integration of PharmIA within the Montpellier University Hospital, as it will do in the various care centres equipped with its solutions.

Translated from La solution PharmIA arrive dans les CHU afin que l’IA puisse résoudre les enjeux actuels de la pharmacie clinique

Recevoir une notification en cas d'actualité importante    OK Non merci